Table 2.
Univariable analysis of recipient characteristics
| Group 2 | Group 3+ | P-value | |
|---|---|---|---|
| (n = 108) | (n = 108) | ||
| Gender, n (%) | |||
| Male | 58 (53.7) | 57 (52.8) | 0.89 |
| Female | 50 (46.3) | 51 (47.2) | |
| Age (years), mean (SD) | 43.9 (±1.7) | 43.2 (±1.5) | 0.72 |
| BMI (kg/m2), mean (SD) | 25.7 (±0.46) | 24.2 (±0.3) | 0.01 |
| cPRA (%), median (range) | 0 (0–95) | 5 (0–92) | 0.004 |
| hPRA (%), median (range) | 5 (0–100) | 32 (0–100) | 0.0001 |
| Comorbidities, n (%) | |||
| Diabetes mellitus | 19 (20.7) | 28 (26.2) | 0.36 |
| Cardiac disease | 35 (38.9) | 43 (40.2) | 0.853 |
| Atherosclerosis | 5 (5.7) | 23 (21.5) | 0.002 |
| COPD | 6 (6.6) | 8 (7.6) | 0.78 |
| HCV | 12 (13.5) | 31 (28.7) | 0.01 |
Data are expressed as mean and standard deviation and median and range. P < 0.05.
COPD, chronic obstructive pulmonal disease; HCV, hepatitis C virus.